It occurred to me that we may not know yet enough about gene expression
changes with regard to development aging (esp. post-translational) to root
them in either the cellular atrophy / hypertrophy sections of aging or the
DNA mutations section (regarding RNAi and methylation).
Holding epigenetic post-translational gene expression both as part of the
other aging problems or as its own problem would be speculative, but doesn't
it deserve its own category to make sure to cover all bases?
I am not up to date with how e.g. the gerontologists view this issue
at the moment, but if anyone has information on the present status
in mainstream life science, I'd be happy if you could post more about it.
What makes me think that expression should perhaps be considered
as SENS pillar #8 (or at least mentioned in more detail, maybe renaming
DNA "mutations" to DNA "changes"), is that AFAIK, many interactions of
siRNA / snRNA can occur later in life, and can trigger hundreds to thousands of
gene expression activation/inactivation changes, leading to degenerative disease.
Two important reasons:
One, as long as SENS would use targeted cell replacement and/or gene therapy,
it MIGHT cover this damage under cell loss/hypertrophy and DNA mutation
remediation, but this is not assured - especially if approaches like the
somatic protein therapy, which looks more practical, will be used.
Worst cases without controlling expression regulation might be when siRNA interactions
trigger gene expressions over a vast range of cells, so that whole organs with intact DNA
suffer from destructive metaplasia (then, the only method would be organ transplantation).
And, in case we find out that some gene therapy approaches (due to the viral vectors, or
due to gene changes at all) would trigger changes in gene expression elsewhere - so that
gene therapy may be devastating unless siRNA/snRNA interactions may be controlled. Even
if gene therapy, we may find that DNA repairing (and remethylating) may not be enough in
the long run and that some more post-transcriptional things have to be understood, if
they represent yet-unknown aging markers and interfere even with transcription in junk-free
cells with intact DNA.
Anyhow, I don't mean to be negative with this, I don't think that even if extra aging
mechanisms of this kind exist, that they'd be orders of magnitude harder. The positive
aspect about acknowledging a potential eigth aging would be another SENS frontier that
overlaps with very latest mainstream research with corresponding project opportunities.
And should this plays a big role in molecular aging, then it's very important to include on
the list. However, if not, some of the other aging-damage could be regulated easier if
SENS research acknowledges development of snRNA/siRNA 'tools' as important, i.e., it
might be that some of the gene therapy needed by SENS is easier accomplished by triggering
gene silencing and activation using those mechanisms than actually modifying DNA.